Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians – The Lancet

Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians  The Lancet

Follow this link:

Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians - The Lancet

Related Posts
Tags: